Clinical Trials on Nasopharyngeal Neoplasms

Total 107457 results

Zhejiang Cancer Hospital

Recruiting

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Nasopharyngeal Carcinoma

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Sun Yat-sen University

Recruiting

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Not yet recruiting

Peramprizumab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Sun Yat-sen University

Recruiting

Olfactory Change After Chemo-radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Kuwait Cancer Control Center

Recruiting

Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Kuwait
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Not yet recruiting

The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Zhejiang Cancer Hospital; Jiangxi Provincial Cancer Hospital

Recruiting

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Nasopharyngeal Carcinoma

China
Zhongshan People's Hospital, Guangdong, China
Wuzhou Red Cross Hospital; Xiamen University

Recruiting

Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Sun Yat-sen University

Not yet recruiting

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

Nasopharyngeal Carcinoma
National Cancer Centre, Singapore
National Taiwan University Hospital; National University of Singapore

Recruiting

Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Singapore
Sun Yat-sen University
The First Affiliated Hospital of Guangzhou Medical University; Affiliated Cancer... and other collaborators

Recruiting

Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Bristol-Myers Squibb

Active, not recruiting

Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma (PLATINUM)

Nasopharyngeal Carcinoma

China
Akeso
Akeso Tiancheng, Inc

Active, not recruiting

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Active, not recruiting

Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Active, not recruiting

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Terminated

Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Akeso
Akeso Pharmaceuticals, Inc.

Completed

A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Active, not recruiting

Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Hubei Cancer Hospital

Completed

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Guilin Medical College; First People's Hoapital of Foshan

Completed

Individualized Elective Neck Irradiation Based on MRI in NPC Patients (NPC-CTVn)

Nasopharyngeal Carcinoma

China
Fudan University

Completed

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Nasopharyngeal Carcinoma

China
Johns Hopkins University
National University Hospital of Singapore

Withdrawn

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Singapore
Xiayun He, MD

Completed

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
University of Malaya
Merck Serono International SA

Terminated

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Malaysia
Sun Yat-sen University
Peking University; Xiangya Hospital of Central South University; Henan Cancer... and other collaborators

Active, not recruiting

Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (CAN)

Nasopharyngeal Carcinoma

China
King Faisal Specialist Hospital & Research Center

Completed

Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA

Nasopharyngeal Carcinoma

Saudi Arabia
Xinqiao Hospital of Chongqing

Completed

3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Radiotherapy

China
Sun Yat-sen University
Guilin Medical University, China; Fifth Affiliated Hospital, Sun Yat-Sen University and other collaborators

Unknown

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Nasopharyngeal Carcinoma

China
Wei Jiang
Guilin Hospital of Traditional Chinese Medicine

Unknown

Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
argenx

Completed

A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

Cancer

Belgium
Zhejiang Cancer Hospital

Unknown

TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Taizhou Hospital

Completed

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Ninth People's Hospital Affiliated to...
Fudan University

Completed

Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
The University of Hong Kong-Shenzhen Hospital

Completed

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital

Unknown

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Yuan-hong Gao

Completed

Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy

Nasopharyngeal Carcinoma
Yun-fei Xia

Unknown

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Nasopharyngeal Carcinoma

China
Pamela Youde Nethersole Eastern Hospital

Completed

NBI to Detect Post-RT Mucosal Residual NPC

Nasopharyngeal Carcinoma

Hong Kong
Taichung Veterans General Hospital

Unknown

Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Taiwan
Sun Yat-sen University

Unknown

Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Unknown

Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC (TIL)

Nasopharyngeal Carcinoma

China
Capital Medical University
Beijing Friendship Hospital; Cancer Institute and Hospital, Chinese Academy...

Unknown

Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Unknown

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Sun Yat-sen University
Chinese Southwest Oncology Group

Unknown

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sanofi

Completed

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Carcinoma | Nasopharyngeal Neoplasms

France, Korea, Republic of, Turkey, Algeria, Brazil, China, India, Indonesia, Italy, Mexico, Morocco, Philippines, Thailand, Tunisia

3

Subscribe